United States · FDA National Drug Code directory
Cleviprex
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10122-611_e472cde4-d29e-44b2-b1ca-a6f4fcc01b1d
- Product NDC
- 10122-611
- Form
- EMULSION
- Composition / generic term
- clevipidine
- Labeler
- Chiesi USA, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20080915
- Source listing expiry
- 20261231
Source-listed ingredients
- CLEVIDIPINE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 CARTON in 1 CARTON (10122-611-10) / 1 VIAL, SINGLE-USE in 1 CARTON (10122-611-01) / 100 mL in 1 VIAL, SINGLE-USE · 10122-611-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →